Study finds heart muscle cells resilient to microgravity during spaceflight

For decades, space agencies have tracked what weightlessness does to the human body—the fluid shift that puffs the face, the spine's slight elongation, the slow drain of bone and muscle mass. But the heart has always loomed larger in the concern. It is the organ that cannot be trained away, cannot be replaced. So when researchers at the University of Chicago sent five mice to the International Space Station and kept five on Earth as a control, they were asking a question that mattered: Could the heart survive the long haul to Mars?

The study ran for approximately 38.5 days. Mice were the logical choice because their hearts beat six to ten times faster than human hearts—up to 600 beats per minute compared to our 60 to 100. If a mouse heart could weather microgravity without weakening, the logic went, a human heart likely could too. The researchers were looking for cellular damage, for the kind of deterioration that had already been documented in skeletal muscle. They expected to find it.

They did not. When the study concluded, the heart muscle cells from the mice that had orbited Earth showed no significant loss of strength. The cells appeared largely resilient to the weightless environment, and the researchers found evidence suggesting they could endure even longer periods in microgravity without failing. Dr. Jonathan Kirk, an associate professor of medicine at UChicago and co-author of the study, described the finding as unexpected relief. "There are a lot of things in common between cardiac and skeletal muscle," he said, "so we thought that we would see some decrease in heart function from space travel. But in the end, we're pretty happy that this is the result we found."

Yet the study was not entirely clean. The researchers detected inflammation markers in the heart muscle cells—a sign of cellular stress that demands further investigation. This finding, published in the journal npj Microgravity, opens a new line of inquiry even as it closes an old worry. The inflammation suggests the heart is working harder to adapt, even if it is not failing. Understanding what drives that inflammatory response could be crucial for astronauts on missions lasting months or years.

The timing of this research is not incidental. The current record for continuous spaceflight stands just under 438 days. A crewed mission to Mars and back would stretch two to three years—a duration that demands certainty about what the human body can withstand. Astronauts aboard the ISS already spend 2.5 hours per day, six days a week, exercising to counteract microgravity's effects, though only about 1.5 hours of that is actual physical activity; the rest goes to equipment setup and hygiene. If the heart is going to hold up, the research pipeline needs to keep flowing.

The team's next steps involve collecting heart tissue samples directly aboard the ISS, rather than waiting for them to return to Earth. The re-entry process subjects samples to crushing gravitational forces that can degrade the cellular structures researchers need to examine. Fresher samples, gathered in orbit and studied before the journey home, could reveal details that current methods miss. As missions grow longer and destinations grow farther, the margin for unknown risks shrinks. This study suggests the heart may not be that risk—but the work is far from finished.